Latest Share Chat

Scancell Holdings Share News (SCLP)

Scancell Holdings Information

Buy SCLP Shares
Add SCLP to Watchlist
Add SCLP to Alert

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 10.00

Bid: 9.50

Ask: 10.50

Change: 0.25 (2.56%)

Spread: 1.00 (10.526%)

Open: 9.75

High: 10.00

Low: 9.75

Prev. Close: 9.75

Last checked at -

Scancell Holdings widens full year loss on US investment

Fri, 16th Sep 2016 14:24

(ShareCast News) - Scancell Holdings, a developer of novel immunotherapies for the treatment of cancer, has reported a third consecutive full year loss due to the costs involved in its expansion in the US.The firm has seen a 3% increase in its operating loss over the last three years. The loss was £2.58m for the year ending 30 April 2016 compared to £2.41m in the previous period. The firm attributed this to the additional corporate costs incurred in preparing and developing opportunities within the US.Post-period the firm has expanded its operations with new offices in San Diego in the US as well as Oxford in the UK to support its growth plans.The group's cash balance was £6.52m at 30 April 2016, compared to £3.06m in the previous period, and net assets rose to £9.99m from £6.75m in the previous period.The company's placing and open offer involving both existing and new shareholders raised £6.2m during the period.Despite its losses, the firm was positive on the development of its cancer treatment. The clinical trial for its SCIB1 treatment continues to deliver significant survival data in patients with stage III/IV cancer. Out of the 20 patients with resected tumours who participated in the trial, 19 remain alive.The firm also continues to make progress in the development of its lead product Modi-1 by collaborating with Karonlinska Institutet to explore the role of citrullination in cancer.Newly appointed executive Chairman Dr John Chiplin said: "We now have the opportunity to transform the business from a small UK-based and largely scientifically-based enterprise into an international force in immuno-oncology. We remain committed to driving this process forward in the US and elsewhere, and to realising the value that has been accumulating over recent years, both for the benefit of our shareholders and cancer patients."The share price fell 4.12% to 16.30p at 16:16 BST on Friday.

More News

24 Oct 2018 12:28

Oxford Technology VCTs Mostly Report Drop In Net Asset Value

LONDON (Alliance News) - The Oxford Technology-managed venture capital trusts reported interim results on Wednesday, with all but one see a drop in net asset value.Oxford Technology Venture

24 Oct 2018 10:43

WINNERS & LOSERS SUMMARY: Metro Bank Down Amid Mortgage Competition

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 0.9%. The bank reported a rise in third by

23 Oct 2018 15:59

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 24 OctoberIndigovisionBeeks FinancialReddePhoto-Me 25 & Smart 26 29 30

25 Sep 2018 11:51

Scancell Well Placed To Keep Pushing Forward Cancer Treatment Work

LONDON (Alliance News) - Immunotherapy firm Scancell Holdings PLC on Tuesday said it is well funded to progress its range of proposed cancer immunotherapies.Scancell is developing for based

18 Sep 2018 16:19

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 19 September KingfisherHalf Year ResultsBabcock InternationalTrading Year Year

24 Jul 2018 12:26

Hygea VCT Net Asset Value Shrinks In First Half On Portfolio Value

LONDON (Alliance News) - Hygea VCT PLC on Tuesday said net asset value decreased in the first half of its current financial year due to a fall in value of its AIM-listed portfolio in the venture a

23 May 2018 14:29

Scancell To Receive European Patent For Moditope Platform In June

LONDON (Alliance News) - Scancell Holdings PLC on Wednesday said it will secure a European patent for its Moditope immunotherapy platform in mid-June.The cancer treatment developer said the

8 May 2018 11:16

Scancell Holdings Raises GBP1.2 Million Via Share Open Offer (ALLISS)

LONDON (Alliance News) - Scancell Holdings PLC said Tuesday that it has raised GBP1.2 million through an open offer of 10.1 million shares at a price of 12.0 pence per share.Shares in the a

3 May 2018 13:43

Hygea VCT Increases NAV Per Share, Changes RBS Overdraft To Loan

LONDON (Alliance News) - Hygea VCT PLC said on Thursday its net present value per share increased in the recent quarter.At March 31, Hygea's NAV per share was 64.4p, up from 63.8p at of

18 Apr 2018 15:09

UPDATE: Scancell Raises GBP7.5 Million, Makes Antibody Acquisition (ALLISS)

LONDON (Alliance News) - Immunotherapy developer Scancell Holdings PLC said Wednesday that it raised GBP7.5 million via a placing of 57.4 million shares and a subscription of 5.0 million shares at

18 Apr 2018 11:44

Scancell Announces GBP8 Million Fundraise, Makes Antibody Acquisition (ALLISS)

LONDON (Alliance News) - Immunotherapy developer Scancell Holdings PLC said Wednesday that it will raise up to GBP8.0 million via equity issue and also announced a technology shares were down 20%

3 Apr 2018 11:02

Scancell Signs Manufacturing Agreement With PolyPeptide Group

LONDON (Alliance News) - Cancer treatment developer Scancell Holdings PLC said on Tuesday it has signed a manufacturing agreement with therapeutic peptide manufacturer the f T

19 Oct 2016 11:05

Oxford Technology Venture Capital Funds Suffer Value Drop

10 Oct 2016 11:42

Scancell to develop ImmunoBody lung cancer treatment

(ShareCast News) - Cancer immunotherapy development company Scancell Holdings announced on Monday its intention to develop its SCIB2 ImmunoBody for the treatment of non-small cell lung cancer in combination with a checkpoint inhibitor. The AIM-traded firm's board approved the decision based on the o

Latest Share Chat

Scancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scancell Holdings widens full year loss on US investment

Login to your account

Quickpicks are a member only feature

Login to your account